US Stock MarketDetailed Quotes

BNTX BioNTech

Watchlist
  • 98.390
  • -6.960-6.61%
Close Mar 11 16:00 ET
  • 99.000
  • +0.610+0.62%
Post 20:01 ET
23.61BMarket Cap-32.79P/E (TTM)

BioNTech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-96.13%207.7M
-154.45%-463.3M
-178.76%-638.9M
-62.91%1.63B
53.16%-317.3M
-60.44%5.37B
2.62%850.9M
-83.03%811.2M
11.93%4.39B
-116.73%-677.4M
Net income from continuing operations
-157.14%-677.7M
-54.58%301.2M
-30.21%158.7M
-95.49%-805.8M
-146.88%-331.8M
-90.84%1.19B
-79.10%663.2M
-90.70%227.4M
-117.77%-412.2M
-85.90%707.7M
Operating gains losses
11.37%-105.2M
-162.47%-28.3M
-101.46%-41.5M
96.92%-8.4M
-120.85%-27M
-130.82%-118.7M
-91.37%45.3M
-118.05%-20.6M
-5.82%-272.9M
2,983.33%129.5M
Depreciation and amortization
62.49%298M
109.90%165.4M
7.51%44.4M
56.43%49.9M
21.97%38.3M
48.74%183.4M
171.72%78.8M
23.28%41.3M
-3.92%31.9M
13.77%31.4M
Other non cash items
45.03%-701.1M
5.68%-149.4M
-58.73%-239.2M
10.60%-140M
78.70%-172.5M
-328.16%-1.28B
-89.70%-158.4M
-2,854.90%-150.7M
-7,557.14%-156.6M
-281.26%-809.8M
Change In working capital
-78.11%1.22B
-478.72%-692.3M
-205.61%-675.3M
-49.72%2.37B
366.46%222.5M
23.38%5.57B
112.47%182.8M
-77.83%639.4M
80.73%4.7B
-90.41%47.7M
-Change in receivables
-92.79%387.7M
-205.52%-879.9M
-231.53%-830.2M
-61.33%1.6B
-44.26%498.2M
22.98%5.37B
55.47%-288M
-71.89%631.2M
30.31%4.14B
321.51%893.8M
-Change in inventory
-9.04%74.5M
-65.69%19.9M
11.45%37M
121.37%5.3M
-20.65%12.3M
30.21%81.9M
140.06%58M
-54.46%33.2M
-127.07%-24.8M
-64.12%15.5M
-Change in payables and accrued expense
537.85%758.4M
-59.38%167.7M
571.60%117.9M
28.36%760.8M
66.57%-288M
38.74%118.9M
161.19%412.8M
-104.42%-25M
189.38%592.7M
-200.48%-861.6M
Cash from discontinued investing activities
Operating cash flow
-96.13%207.7M
-154.45%-463.3M
-178.76%-638.9M
-62.91%1.63B
53.16%-317.3M
-60.44%5.37B
2.62%850.9M
-83.03%811.2M
11.93%4.39B
-116.73%-677.4M
Investing cash flow
Cash flow from continuing investing activities
70.07%-2.08B
122.51%606.7M
88.47%-142.1M
89.47%-241.4M
-213.35%-2.3B
-19,601.13%-6.95B
-1,573.98%-2.7B
-1,379.23%-1.23B
-2,823.21%-2.29B
-355.88%-735.4M
Net PPE purchase and sale
-14.07%-285.3M
21.27%-65.9M
-34.26%-72.5M
-31.55%-88.4M
-29.42%-58.5M
23.89%-250.1M
38.64%-83.7M
30.32%-54M
4.82%-67.2M
-2.49%-45.2M
Net intangibles purchase and sale
63.59%-165.8M
77.00%-24.5M
89.51%-10.2M
78.23%-52.7M
-716.67%-78.4M
-1,235.48%-455.4M
-1,248.10%-106.5M
-1,968.09%-97.2M
-4,943.75%-242.1M
42.51%-9.6M
Net business purchase and sale
--0
--0
--0
----
----
---336.9M
--0
---336.9M
----
----
Net investment purchase and sale
72.43%-1.63B
127.83%697.1M
92.02%-59.4M
94.94%-100.3M
-218.47%-2.17B
-1,905.77%-5.91B
-14,899.40%-2.5B
-67,545.45%-744.1M
-65,983.33%-1.98B
-295.46%-680.6M
Cash from discontinued investing activities
Investing cash flow
70.07%-2.08B
122.51%606.7M
88.47%-142.1M
89.47%-241.4M
-213.35%-2.3B
-19,601.13%-6.95B
-1,573.98%-2.7B
-1,379.23%-1.23B
-2,823.21%-2.29B
-355.88%-735.4M
Financing cash flow
Cash flow from continuing financing activities
94.10%-45.9M
43.41%-7.3M
97.46%-7.9M
85.99%-22.9M
97.32%-7.8M
45.14%-778.6M
80.06%-12.9M
52.40%-311M
79.09%-163.4M
-462.76%-291.3M
Net issuance payments of debt
-14.46%-45.9M
39.67%-7.3M
15.05%-7.9M
-143.62%-22.9M
16.13%-7.8M
32.15%-40.1M
-34.44%-12.1M
3.13%-9.3M
8.74%-9.4M
69.21%-9.3M
Net common stock issuance
--0
--0
--0
--0
--0
15.69%-738.5M
98.56%-800K
53.14%-301.7M
46.32%-154M
-355.20%-282M
Cash dividends paid
--0
----
----
----
----
--0
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
94.10%-45.9M
43.41%-7.3M
97.46%-7.9M
85.99%-22.9M
97.32%-7.8M
45.14%-778.6M
80.06%-12.9M
52.40%-311M
79.09%-163.4M
-462.76%-291.3M
Net cash flow
Beginning cash position
-15.94%11.66B
-28.68%9.62B
-26.75%10.38B
-26.08%8.98B
-15.94%11.66B
719.70%13.88B
0.54%13.5B
51.76%14.17B
97.01%12.14B
719.70%13.88B
Current changes in cash
18.73%-1.92B
107.33%136.1M
-7.77%-788.9M
-29.44%1.36B
-54.30%-2.63B
-119.48%-2.36B
-407.72%-1.86B
-118.11%-732M
-36.86%1.93B
-138.57%-1.7B
Effect of exchange rate changes
202.07%14.8M
109.73%13.6M
-103.76%-2.3M
-103.62%-3.3M
125.09%6.8M
-124.13%-14.5M
7.78%-139.8M
31.05%61.2M
-18.21%91.2M
-150.65%-27.1M
End cash Position
-16.31%9.76B
-16.31%9.76B
-28.68%9.62B
-26.75%10.38B
-26.08%8.98B
-15.94%11.66B
-15.94%11.66B
0.54%13.5B
51.76%14.17B
97.01%12.14B
Free cash flow
-105.24%-244.6M
-183.91%-554.4M
-209.38%-721.9M
-63.56%1.49B
37.97%-454.2M
-64.69%4.67B
-3.51%660.7M
-85.95%660M
6.08%4.08B
-118.35%-732.2M
Currency Unit
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -96.13%207.7M-154.45%-463.3M-178.76%-638.9M-62.91%1.63B53.16%-317.3M-60.44%5.37B2.62%850.9M-83.03%811.2M11.93%4.39B-116.73%-677.4M
Net income from continuing operations -157.14%-677.7M-54.58%301.2M-30.21%158.7M-95.49%-805.8M-146.88%-331.8M-90.84%1.19B-79.10%663.2M-90.70%227.4M-117.77%-412.2M-85.90%707.7M
Operating gains losses 11.37%-105.2M-162.47%-28.3M-101.46%-41.5M96.92%-8.4M-120.85%-27M-130.82%-118.7M-91.37%45.3M-118.05%-20.6M-5.82%-272.9M2,983.33%129.5M
Depreciation and amortization 62.49%298M109.90%165.4M7.51%44.4M56.43%49.9M21.97%38.3M48.74%183.4M171.72%78.8M23.28%41.3M-3.92%31.9M13.77%31.4M
Other non cash items 45.03%-701.1M5.68%-149.4M-58.73%-239.2M10.60%-140M78.70%-172.5M-328.16%-1.28B-89.70%-158.4M-2,854.90%-150.7M-7,557.14%-156.6M-281.26%-809.8M
Change In working capital -78.11%1.22B-478.72%-692.3M-205.61%-675.3M-49.72%2.37B366.46%222.5M23.38%5.57B112.47%182.8M-77.83%639.4M80.73%4.7B-90.41%47.7M
-Change in receivables -92.79%387.7M-205.52%-879.9M-231.53%-830.2M-61.33%1.6B-44.26%498.2M22.98%5.37B55.47%-288M-71.89%631.2M30.31%4.14B321.51%893.8M
-Change in inventory -9.04%74.5M-65.69%19.9M11.45%37M121.37%5.3M-20.65%12.3M30.21%81.9M140.06%58M-54.46%33.2M-127.07%-24.8M-64.12%15.5M
-Change in payables and accrued expense 537.85%758.4M-59.38%167.7M571.60%117.9M28.36%760.8M66.57%-288M38.74%118.9M161.19%412.8M-104.42%-25M189.38%592.7M-200.48%-861.6M
Cash from discontinued investing activities
Operating cash flow -96.13%207.7M-154.45%-463.3M-178.76%-638.9M-62.91%1.63B53.16%-317.3M-60.44%5.37B2.62%850.9M-83.03%811.2M11.93%4.39B-116.73%-677.4M
Investing cash flow
Cash flow from continuing investing activities 70.07%-2.08B122.51%606.7M88.47%-142.1M89.47%-241.4M-213.35%-2.3B-19,601.13%-6.95B-1,573.98%-2.7B-1,379.23%-1.23B-2,823.21%-2.29B-355.88%-735.4M
Net PPE purchase and sale -14.07%-285.3M21.27%-65.9M-34.26%-72.5M-31.55%-88.4M-29.42%-58.5M23.89%-250.1M38.64%-83.7M30.32%-54M4.82%-67.2M-2.49%-45.2M
Net intangibles purchase and sale 63.59%-165.8M77.00%-24.5M89.51%-10.2M78.23%-52.7M-716.67%-78.4M-1,235.48%-455.4M-1,248.10%-106.5M-1,968.09%-97.2M-4,943.75%-242.1M42.51%-9.6M
Net business purchase and sale --0--0--0-----------336.9M--0---336.9M--------
Net investment purchase and sale 72.43%-1.63B127.83%697.1M92.02%-59.4M94.94%-100.3M-218.47%-2.17B-1,905.77%-5.91B-14,899.40%-2.5B-67,545.45%-744.1M-65,983.33%-1.98B-295.46%-680.6M
Cash from discontinued investing activities
Investing cash flow 70.07%-2.08B122.51%606.7M88.47%-142.1M89.47%-241.4M-213.35%-2.3B-19,601.13%-6.95B-1,573.98%-2.7B-1,379.23%-1.23B-2,823.21%-2.29B-355.88%-735.4M
Financing cash flow
Cash flow from continuing financing activities 94.10%-45.9M43.41%-7.3M97.46%-7.9M85.99%-22.9M97.32%-7.8M45.14%-778.6M80.06%-12.9M52.40%-311M79.09%-163.4M-462.76%-291.3M
Net issuance payments of debt -14.46%-45.9M39.67%-7.3M15.05%-7.9M-143.62%-22.9M16.13%-7.8M32.15%-40.1M-34.44%-12.1M3.13%-9.3M8.74%-9.4M69.21%-9.3M
Net common stock issuance --0--0--0--0--015.69%-738.5M98.56%-800K53.14%-301.7M46.32%-154M-355.20%-282M
Cash dividends paid --0------------------0----------------
Cash from discontinued financing activities
Financing cash flow 94.10%-45.9M43.41%-7.3M97.46%-7.9M85.99%-22.9M97.32%-7.8M45.14%-778.6M80.06%-12.9M52.40%-311M79.09%-163.4M-462.76%-291.3M
Net cash flow
Beginning cash position -15.94%11.66B-28.68%9.62B-26.75%10.38B-26.08%8.98B-15.94%11.66B719.70%13.88B0.54%13.5B51.76%14.17B97.01%12.14B719.70%13.88B
Current changes in cash 18.73%-1.92B107.33%136.1M-7.77%-788.9M-29.44%1.36B-54.30%-2.63B-119.48%-2.36B-407.72%-1.86B-118.11%-732M-36.86%1.93B-138.57%-1.7B
Effect of exchange rate changes 202.07%14.8M109.73%13.6M-103.76%-2.3M-103.62%-3.3M125.09%6.8M-124.13%-14.5M7.78%-139.8M31.05%61.2M-18.21%91.2M-150.65%-27.1M
End cash Position -16.31%9.76B-16.31%9.76B-28.68%9.62B-26.75%10.38B-26.08%8.98B-15.94%11.66B-15.94%11.66B0.54%13.5B51.76%14.17B97.01%12.14B
Free cash flow -105.24%-244.6M-183.91%-554.4M-209.38%-721.9M-63.56%1.49B37.97%-454.2M-64.69%4.67B-3.51%660.7M-85.95%660M6.08%4.08B-118.35%-732.2M
Currency Unit EUREUREUREUREUREUREUREUREUREUR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Alibaba
BABA
+4.89%
Tesla
TSLA
+3.79%
Netflix
NFLX
+3.28%
Broadcom
AVGO
+3.06%
Micron Technology
MU
+2.26%

Unlock the Full List

Investment Theme Infectious Disease
Infectious Disease
Intraday-1.97%